NEW YORK (GenomeWeb News) - The National Institutes of Health extended the submission date for its Commercialization Assistance Program to Aug. 7.
 
The NIH SBIR CAP connects SBIR Phase II awardees with partners and investors to help move the products into the marketplace. The program is appropriate for researchers with clinical products looking for investments or alliances.
 
STTR awardees are not eligible to participate at this time.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.